-
A variety of methods and medications are available to treat nausea and vomiting in pregnancy one of the most common and often vexing problems for pregnant women.
-
This review outlines steps that OB/GYNs can take to support their patients who desire to breastfeed.
-
After pelvic floor reconstructive surgery, antibiotic prophylaxis with daily nitrofurantoin during postoperative catheterization does not decrease risk of urinary tract infection.
-
Levator myalgia is a prevalent condition in women presenting with pelvic floor symptoms and is associated with greater symptom bother. Fibromyalgia is associated with an increased risk of levator ani myalgia in women presenting with prolapse.
-
In this cross-sectional survey of 333 women, the majority reported current pubic hair removal (87%), and two-thirds reported removing all their pubic hair. Most women (60%) had experienced at least one complication because of the removal, the most common complications being epidermal abrasions and ingrown hairs.
-
The findings in a recent study in which investigators evaluated the relative contributions of pre-pregnant weight, weight gain in pregnancy, and the presence of gestational diabetes on the rate of large-for-gestational age fetuses has shed light on how this true complication of pregnancy can be diminished.
-
Selective estrogen receptor modulators (SERMs) like tamoxifene and raloxifene are now well-established therapeutics, and new agents such as bazedoxifene and ospemifene have recently been introduced. These new agents have unique tissue-specific profiles that allow for a customization of therapeutic effect. In this review, the profiles of bazedoxifene and ospemifene will be compared and discussed relevant to their place in clinical practice.
-
Publication of the newly updated Sexually Transmitted Diseases Treatment Guidelines from the Centers for Disease Control and Prevention is on its way. The proposed new guidance, which replaces information published in 2010, will provide the latest evidence-based treatment recommendations.
-
To evaluate possible drug-drug interactions with combined pills, clinicians need to understand how the estrogen and progestin in pills are absorbed, distributed, metabolized, and eliminated.
-
The need for new contraception options is clear. In the United States, about half of the some 3.4 million pregnancies each year are unintended.
